Inventor · disambiguated record
Chigusa Yoshimura
Also filed as: YOSHIMURA CHIGUSA
6 granted patents·2 pending applications·12 citations·filing 2013–2024
74Inventor score
Top patents by PatentIndex Score
8 records- 0185US9481733B2Anti-FGFR2 antibodies and pharmaceutical compositions thereofDAIICHI SANKYO CO LTD·Filed 2015·Granted Nov 1, 2016·6 cites·43 claims
- 0281US9714298B2Anti-FGFR2 antibodies and methods of use thereof for treating cancerDAIICHI SANKYO CO LTD·Filed 2013·Granted Jul 25, 2017·6 cites·46 claims
- 0378US12486329B2Anti-SIRPα antibodyUNIV KOBE NAT UNIV CORP·Filed 2024·Granted Dec 2, 2025·0 cites·21 claims
- 0467US2023287119A1Anti-cd3 antibody and molecules comprising the antibodyDAIICHI SANKYO CO LTD·Filed 2023·Application pending·0 cites
- 0565US12024566B2Anti-SIRPalpha antibodyUNIV KOBE NAT UNIV CORP·Filed 2019·Granted Jul 2, 2024·0 cites·29 claims
- 0659US11618785B2Anti-CD3 antibody and molecules comprising the antibodyDAIICHI SANKYO CO LTD·Filed 2017·Granted Apr 4, 2023·0 cites·41 claims
- 0751US2020085946A1Monoclonal antibodies to human fibroblast growth factor receptor 2 (hfgfr2) and methods of use thereofDAIICHI SANKYO CO LTD·Filed 2019·Application pending·0 cites
- 0841US10881734B2Monoclonal antibodies to human fibroblast growth factor receptor 2 (HFGFR2) and methods of use thereofDAIICHI SANKYO CO LTD·Filed 2016·Granted Jan 5, 2021·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Chigusa Yoshimura files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →